This company has been marked as potentially delisted and may not be actively trading. NASDAQ:NVCN Neovasc (NVCN) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Neovasc Stock (NASDAQ:NVCN) 30 days 90 days 365 days Advanced Chart Get Neovasc alerts:Sign Up Key Stats Today's Range$30.03▼$30.0350-Day Range$29.03▼$30.0352-Week Range$4.59▼$30.07Volume1 shsAverage Volume56,993 shsMarket Capitalization$82.28 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Neovasc, Inc. engages in the development, manufacture and marketing of medical devices. It focuses on Neovast Tiara and Neovasc Reducer products. The company was founded on November 2, 2000 and is headquartered in Richmond, Canada. Read More Receive NVCN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Neovasc and its competitors with MarketBeat's FREE daily newsletter. Email Address NVCN Stock News HeadlinesClosing Bell: Neovasc Inc down on Tuesday (NVCN)April 15, 2023 | theglobeandmail.comClosing Bell: Neovasc Inc up on Monday (NVCN)April 11, 2023 | theglobeandmail.comBiotech Alert: With news on MPox, RSV, and more, this tiny firm could disrupt a $3B marketA small biotech is stepping into the spotlight with a first-in-class antiviral platform—and it could be one of the market’s most overlooked opportunities today. NanoViricides, Inc. (NYSE: NNVC) is advancing NV-387, a broad-spectrum antiviral now in human trials, with activity against COVID-19, RSV, influenza, measles, and most recently Mpox. With Phase II trials approved in Africa for the deadliest Mpox strain, the timing couldn’t be more critical.August 18 at 2:00 AM | Smallcaps Daily (Ad)Neovasc Announces Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Corporate UpdateMarch 31, 2023 | finance.yahoo.comNeovasc's (TSE:NVCN) investors will be pleased with their solid 171% return over the last yearMarch 9, 2023 | finance.yahoo.comNeovasc Shareholders Approve Acquisition by Shockwave MedicalMarch 6, 2023 | finance.yahoo.comNeovasc Announces German Reimbursement RenewalFebruary 1, 2023 | finance.yahoo.comNeovasc (NVCN) is on the Move, Here's Why the Trend Could be SustainableJanuary 11, 2023 | finance.yahoo.comSee More Headlines NVCN Stock Analysis - Frequently Asked Questions How were Neovasc's earnings last quarter? Neovasc Inc. (NASDAQ:NVCN) posted its earnings results on Tuesday, November, 9th. The medical equipment provider reported ($2.75) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($2.25) by $0.50. The medical equipment provider earned $0.70 million during the quarter, compared to analysts' expectations of $1.20 million. Neovasc had a negative net margin of 1,082.92% and a negative trailing twelve-month return on equity of 127.25%. When did Neovasc's stock split? Shares of Neovasc reverse split on the morning of Friday, April 29th 2022.The 1-25 reverse split was announced on Friday, April 29th 2022. The number of shares owned by shareholders was adjusted after the market closes on Friday, April 29th 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split. What other stocks do shareholders of Neovasc own? Based on aggregate information from My MarketBeat watchlists, some other companies that Neovasc investors own include Biopharmx (BPMX), Allstate (ALL), NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Micron Technology (MU) and Canopy Growth (CGC). Company Calendar Last Earnings11/09/2021Today8/18/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:NVCN CIK1399708 Webwww.neovasc.com Phone(604) 270-4344Fax604-270-4384Employees49Year FoundedN/AProfitability EPS (Trailing Twelve Months)($15.08) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$41.20 million Net Margins-1,082.92% Pretax Margin-1,082.26% Return on Equity-127.25% Return on Assets-80.31% Debt Debt-to-Equity Ratio0.80 Current Ratio2.96 Quick Ratio2.85 Sales & Book Value Annual Sales$3.81 million Price / Sales21.60 Cash FlowN/A Price / Cash FlowN/A Book Value$5.77 per share Price / Book5.20Miscellaneous Outstanding Shares2,740,000Free FloatN/AMarket Cap$82.28 million OptionableNot Optionable Beta1.70 Social Links Analysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (NASDAQ:NVCN) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersBiotech Alert: With news on MPox, RSV, and more, this tiny firm could disrupt a $3B marketA small biotech is stepping into the spotlight with a first-in-class antiviral platform—and it could be one of...Smallcaps Daily | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | Sponsored"AI Upgrade" Coming Sept. 1stA new “AI Upgrade” is rolling out on September 1st—and tech leaders are calling it transformational. Softbank’...Behind the Markets | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neovasc Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neovasc With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.